|
CN112198243A
|
|
Method for detecting sildenafil citrate impurity
|
|
CN111671797A
|
|
Pharmaceutical composition for preventing and treating atherosclerosis and preparation and application methods thereof
|
|
CN111671841A
|
|
Anti-osteoarthritis pharmaceutical composition and preparation method and application thereof
|
|
CN111658616A
|
|
Cefprozil dry suspension and preparation method thereof
|
|
CN111551654A
|
|
Method for detecting cefixime polymer impurities
|
|
CN111487354A
|
|
Method for detecting cefixime related impurities
|
|
CN111450144A
|
|
Application of ficus microcarpa extract in preparation of medicines for preventing and/or treating diabetes and complications thereof
|
|
CN111450143A
|
|
Application of ficus microcarpa extract in preparation of medicine for preventing and/or treating liver pathological changes
|
|
CN111544412A
|
|
Cefixime composition and preparation method thereof
|
|
CN111388433A
|
|
Sildenafil citrate oral preparation and preparation method thereof
|
|
CN111096997A
|
|
Application of ficus microcarpa extract in preventing or treating interstitial lung diseases
|
|
CN110078736A
|
|
Pyrazolopyrimidine derivative, preparation method and its application
|
|
CN111718344A
|
|
Tadalafil refining method
|
|
CN110862394A
|
|
Preparation method of PDE9A inhibitor
|
|
CN108693293A
|
|
The method for detecting impurity in amoxicillin granules
|
|
CN108693292A
|
|
A kind of detection method of amoxil capsule impurity
|
|
CN108844195A
|
|
A kind of humiture setting value control device and control method
|
|
CN108338978A
|
|
A kind of S- carboxymethyls-L-cysteine enteric-coated pellet capsule
|
|
CN108553439A
|
|
A kind of enteric coated tablet of carboxymethyl containing S--L-cysteine
|
|
CN108324957A
|
|
A kind of S- carboxymethyls-L-cysteine inclusion compound and its enteric-coated formulation composition
|
